Clinical trial

Leukine (Sargramostim) for Parkinson's Disease

NCT01882010

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-09-01

PhasePHASE1

Study timeline

Study start (actual)2013-09-01Date precision: day

Registry last updated2023-10-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Diseaseunresolved

Interventions

sargramostimDRUG · verified · RxNorm: sargramostim

Sham Comparator: ControlsDIAGNOSTIC_TEST

Sponsors & collaborators

University of Nebraskalead sponsor

Sanoficollaborator

National Institute of Neurological Disorders and Stroke (NINDS)collaborator

Nebraska Neuroscience Alliancecollaborator

Mapped research locations

OmahaNebraska, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01882010 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.